NCT01767155: A reported trial by AEterna Zentaris
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT01767155 |
|---|---|
| Title | Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer. |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | April 30, 2013 |
| Completion date | Jan. 30, 2017 |
| Required reporting date | Jan. 30, 2018, midnight |
| Actual reporting date | Jan. 15, 2018 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |